| William R England, MD | |
|
215 E Hawaii Ave, Nampa, ID 83686-6011 | |
| (208) 463-3234 | |
| (208) 463-3044 |
| Full Name | William R England |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 215 E Hawaii Ave, Nampa, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407883978 | NPI | - | NPPES |
| 80094284 | Other | ID | RAIL ROAD MEDICARE |
| 8175598 | Medicaid | WA | |
| 002384100 | Medicaid | ID | |
| 101012 | Other | WA | LABOR & INDUSTRIES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | M-6772 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William R England, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 | William R England, MD 215 E Hawaii Ave, Nampa, ID 83686-6011 Ph: (208) 463-3234 |
News Archive
Researchers investigating the use of Twitter to propagate or debunk conspiracy theories related to the 2015-2016 Zika virus outbreak analyzed the content of more than 25,000 Tweets and the characteristics of the social networks used to disseminate them.
Pharmaceutical companies, which "have been waging war against inexpensive generic drugs for years at the national level," are now "taking their fights to the states, promoting proposals that would" bar pharmacists from automatically replacing prescriptions for brand-name drugs with generics, the Baltimore Sun reports.
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers. The finding suggests a possible target for developing new ways to treat this deadly disease.
Global technology consultancy DataArt announced today the launch of "SkinCareAI" - a prototype app that analyses skin images to detect early signs of melanoma.
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
› Verified 5 days ago
Dr. Richard C Ballantyne, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-364-3000 | |
Dr. Eric Paul Kendall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5100 | |
Thomas Ronay, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 S Middleton Rd, Nampa, ID 83651 Phone: 208-505-2800 | |
John Mullins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 12th Ave Rd, Nampa, ID 83686 Phone: 208-498-1080 | |
Dr. Mitchell D Long, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5100 | |
Dr. Roger Keith Ottman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5100 |